Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding

INTRODUCTION: Factor Xa (fXa) inhibitor reversal for life-threatening bleeding is controversial due to a lack of high-quality evidence. The purpose of this study was to determine the hemostatic efficacy of four-factor prothrombin complex concentrate (4F-PCC) for the reversal of fXa inhibitors compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rech, Megan A., Masic, Dalila, Hammond, Drayton A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2021
Materias:
Health Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972353/
https://www.ncbi.nlm.nih.gov/pubmed/33856296
http://dx.doi.org/10.5811/westjem.2020.11.47931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972353/
https://www.ncbi.nlm.nih.gov/pubmed/33856296
http://dx.doi.org/10.5811/westjem.2020.11.47931

Ejemplares similares